erfonrilimab
alphamab
['kn046', 'solid tumor']
new #jitc article: phase i trial of kn046, a novel bispecific antibody targeting pd-l1 and ctla-4 in patients with advanced solid tumors #asco23 
The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Interim Editor-in-Chief: James L. Gulley (@gulley1)